QRVO - Public offerings

SANTA CLARA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. ("Silvaco") (NASDAQ:SVCO), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced that Dr. Babak Taheri has left the company, effective August 19, 2025, following nearly seven years as Chief Executive Officer, during which he led the company through its initial public offering. The Board has appointed Walden "Wally" C. Rhines, Ph.D., as the company's new Chief Executive Officer, effective immediately. "It has been a great honor to work with the team and the board at Silvaco. I am very proud of our successful

GREENSBORO, N.C., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Qorvo® (NASDAQ:QRVO), a leading provider of innovative RF solutions that connect the world, today announced the completion of its offering of $500 million principal amount of its senior notes maturing in 2024 (the "Notes"). The Notes will pay interest semi-annually at a rate of 1.750%. The Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The Notes were issued to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in accordance with Regulation S under the Sec

ANN ARBOR, Mich., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that while a majority of shareholders voted at its Special Virtual-Only Meeting of Shareholders held on December 15, 2020 in favor of the Company’s proposed domestication to Delaware, shareholders failed to approve the proposal by the necessary 2/3 vote and therefore the domestication will not be implemented. "I would like to sincerely thank our many shareholders who supported management's recommendation and voted in favor of the domestication of Zomedica, which woul

ANN ARBOR, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, with the hiring of Debra Rock to lead the Company’s Marketing Department, its internal commercial leadership team is complete. Joining Zomedica as Senior Director of Downstream Marketing & Communications is Debra Rock. Ms. Rock is an experienced marketing and communications professional, having served in leadership positions in both the human and animal health industries. This experience includes roles at both AngioDynamics, a leading provider of minimally inva